ESR1 and breast cancer: The main dysregulation events of ER contributing to BC initiation and progression are: (i) increasing of the transcriptional activity of ER in an estrogen-independent fashion, (ii) gene amplification of the ER gene, (iii) point mutations in the ER gene, and (iv) genomic rearrangements of the ER gene (reviewed in reference [29]).